Valuation: Abbott Laboratories

Capitalization 20TCr 19TCr 18TCr 16TCr 28TCr 17,02000Cr 32TCr 2,21500Cr 82TCr 6,96800Cr 74TCr 72TCr 30,95300Cr P/E ratio 2024 *
33.3x
P/E ratio 2025 * 28.7x
Enterprise value 20TCr 20TCr 19TCr 17TCr 29TCr 17,58100Cr 33TCr 2,28800Cr 85TCr 7,19800Cr 76TCr 74TCr 31,97400Cr EV / Sales 2024 *
4.83x
EV / Sales 2025 * 4.48x
Free-Float
86.65%
Yield 2024 *
1.95%
Yield 2025 * 2.03%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.78%
1 week-0.56%
Current month+0.07%
1 month-0.59%
3 months-2.52%
6 months+8.61%
Current year+0.07%
More quotes
1 week
111.79
Extreme 111.79
114.69
1 month
111.28
Extreme 111.28
115.95
Current year
111.79
Extreme 111.79
114.69
1 year
99.71
Extreme 99.71
121.64
3 years
89.67
Extreme 89.674
130.94
5 years
61.61
Extreme 61.61
142.60
10 years
36.00
Extreme 36
142.60
More quotes
Director TitleAgeSince
Chief Executive Officer 51 31/03/2020
Director of Finance/CFO 52 01/09/2023
Chief Tech/Sci/R&D Officer - 01/03/2020
Manager TitleAgeSince
Director/Board Member 74 10/10/2008
Director/Board Member 63 09/12/2011
Director/Board Member 66 09/12/2011
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+0.78%-0.56%-0.64%-15.35%19TCr
+1.40%+1.04%-6.44%-24.93%10TCr
+1.08%+3.38%-0.03%-9.82%6.78TCr
-0.04%+3.01%+7.59%+73.97%4.57TCr
-1.35%+2.63%+11.38%+33.43%4.47TCr
+2.67%-1.52%-36.13%-34.87%3.04TCr
-0.12%-0.38%+17.84%+33.36%2.8TCr
+2.37%+1.20%-2.07%-15.37%2.4TCr
+0.91%+0.98%-14.28%-16.00%2.08TCr
+0.79%+1.59%-7.18%-14.20%2.03TCr
Average +0.88%-0.01%-3.00%+1.02% 5.8TCr
Weighted average by Cap. +0.88%-0.12%-1.77%-4.28%
See all sector performances

Financials

2024 *2025 *
Net sales 4.2TCr 4.12TCr 3.86TCr 3.45TCr 6.05TCr 3,64000Cr 6.82TCr 47TCr 18TCr 1,49000Cr 16TCr 15TCr 6,62000Cr 4.5TCr 4.41TCr 4.13TCr 3.7TCr 6.48TCr 3,89900Cr 7.31TCr 51TCr 19TCr 1,59600Cr 17TCr 17TCr 7,09100Cr
Net income 593.35Cr 581.72Cr 545.42Cr 488.06Cr 855.18Cr 51TCr 964.32Cr 6.69TCr 2.48TCr 21TCr 2.23TCr 2.18TCr 94TCr 684.9Cr 671.48Cr 629.58Cr 563.36Cr 987.13Cr 59TCr 1.11TCr 7.73TCr 2.87TCr 24TCr 2.57TCr 2.52TCr 1,08000Cr
Net Debt 647.53Cr 634.84Cr 595.22Cr 532.62Cr 933.26Cr 56TCr 1.05TCr 7.31TCr 2.71TCr 23TCr 2.43TCr 2.38TCr 1,02100Cr 503.99Cr 494.11Cr 463.28Cr 414.55Cr 726.38Cr 44TCr 819.08Cr 5.69TCr 2.11TCr 18TCr 1.89TCr 1.85TCr 79TCr
More financial data * Estimated data
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Employees
1,14,000
Calendar
More about the company
Date Price Change Volume
13/25/13 113.19 $ +0.78% 4,408,749
10/25/10 112.31 $ -1.70% 5,109,130
08/25/08 114.25 $ +0.75% 4,455,770
07/25/07 113.40 $ +0.32% 5,300,212

Delayed Quote Nyse, January 14, 2025 at 02:30 am IST

More quotes
Trading Rating
Investor Rating
ESG MSCI
BB
surperformance-ratings-light-chart ABBOTT-LABORATORIESMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
113.19USD
Average target price
130.62USD
Spread / Average Target
+15.40%
Consensus

Quarterly revenue - Rate of surprise